Breast Implant Industry Analysis in Asia Pacific

Breast Implant Sales Outlook for Asia Pacific (2024 to 2034)

Revenue from breast implant sales in Asia Pacific is projected to reach US$ 267.2 million in 2024 and climb to US$ 542.6 million by 2034, increasing at 7.3% CAGR over the next ten years (2024 to 2034).

Overhaul of Asian beauty standards can be directly linked to globalization and the increasing influence of Western culture in the Asia Pacific region. Fuller busts and curvy figures are beauty standards that have been gaining traction among Asians thereby creating high breast implant demand. Increasing acceptance of cosmetic surgeries, rising prevalence of breast cancer, high availability of cheap breast augmentation procedures, and growing medical tourism are some other key factors that could open up new avenues of opportunities for breast implant companies in Asia Pacific through 2034.

On the contrary, risk of complications in breast implantation and augmentation procedures is estimated to be the key challenge for breast implant companies operating in the Asia Pacific region. Rising focus on improving patient outcomes is estimated to uplift the overall demand for implantable medical devices in Asia Pacific.

• Breast implant sales in the Rest of Asia Pacific are forecasted to rise at a CAGR of 7.4% from 2024 to 2034.

Report Attributes	Details
Breast Implant Sales in Asia Pacific (2024E)	US$ 267.2 Million
Projected Sales (2034F)	US$ 542.6 Million
Demand Growth (2024 to 2034)	7.3% CAGR
Sales in Malaysia (2024E)	US$ 26 Million
Demand Growth in Singapore (2024 to 2034)	6.9% CAGR
China Market Share (2024E)	32.3%
Demand Growth in Cosmetic Surgery Applications (2024 to 2034)	7.7% CAGR
Key Companies Profiled	Mentor Worldwide LLC Allergan GC Aesthetics Establishment Labs Holdings

Can Breast Implant Start-ups Make a Name for Themselves in APAC?

“Increasing Spending on Cosmetic Surgeries Creating New Market Opportunities”

Aesthetic awareness among people in the Asia Pacific region is increasing and beauty trends are also being influenced by social influencers and celebrities. The willingness of people to go to extreme lengths such as surgeries to get the perfect look has created a highly opportune setting for new breast implant suppliers as well as established ones.

New breast implant manufacturing companies are focusing on developing novel technologies to improve the quality of breast implants and resolve the issues associated with the currently available implants.

• In November 2022, Prayasta, a new company based in Bengaluru, India, announced the launch of a new first-of-its-kind 3D printer for implant-grade silicone. Silimac will allow implant makers to produce breast implants with a reduced risk of leakage.

Find more details of growth-augmenting factors such as product standards, pricing trends, safety regulations, local supply, and new developments in this research study on breast implants by skilled analysts at Fact.MR, a market research and competitive intelligence provider.

Country-wise Insights

Thailand, Indonesia, Malaysia, Australia, and India are projected to witness high demand for breast implants in the Asia Pacific region owing to the presence of huge landfills and rising demand for electricity.

Why Should Breast Implant Companies Invest in China?

“Increasing Popularity of Westernized Beauty Idols and Rising Disposable Income”

Attribute	China
Market Value (2024E)	US$ 86 Million
Growth Rate (2024 to 2034)	7.7% CAGR
Projected Value (2034F)	US$ 181 Million

There has been a significant shift in beauty standards in China in recent years owing to the increasing influence of Western beauty standards that emphasize fuller breasts and curvier figures. The growing influence of social media, rising disposable income, increasing cases of breast cancer, and growing availability of novel breast augmentation procedures are key prospects that could bolster breast implant sales in China over the coming years.

Implementation of regulations by the Chinese government to ensure the safety of breast augmentation and breast implantation procedures is also estimated to promote the uptake of breast implants in the country over the next ten years.

How Will Breast Implant Companies Fare in Thailand?

“Increasing Medical Tourism Activity Driving Growth Scope”

Attribute	Thailand
Market Value (2024E)	US$ 43 Million
Growth Rate (2024 to 2034)	7.2% CAGR
Projected Value (2034F)	US$ 86 Million

Getting breast augmentation or any other cosmetic procedures done in Thailand costs much less than other countries around the world and this is projected to primarily augment demand for breast implants over the coming years. High cultural acceptance of people undergoing breast augmentation or breast reconstruction surgeries is also a factor that could benefit breast implant sales in Thailand across the study period.

Category-wise Insights

Breast implant providers in Asia Pacific are focusing on supplying silicone breast implants to hospitals as most breast-related procedures are being performed in a hospital setting due to patient preference for the same.

Which Type of Breast Implants are Widely Popular?

“Most Women Prefer Silicone Breast Implants Over Saline Variants”

Attribute	Silicone Breast Implants
Segment Value (2024E)	US$ 240 Million
Growth Rate (2024 to 2034)	7.4% CAGR
Projected Value (2034F)	US$ 488 Million

Preference for silicone breast implants is high among women all over the world owing to their ability to maintain a robust shape over time. The risk of breast implant rupturing is also relatively low with silicone implants as compared to saline implants. Saline implants have a high risk of rupture and also reveal some rippling from the pressure on natural breast tissue, making it less aesthetically perfect. All of the aforementioned factors are projected to uplift demand for silicone breast implants in the long run.

Where Do Most Breast Implant Sales Come From?

“Hospitals to Lead Breast Implant Demand Growth”

Attribute	Hospitals
Segment Value (2024E)	US$ 180.6 Million
Growth Rate (2024 to 2034)	7.6% CAGR
Projected Value (2034F)	US$ 375.5 Million

Majority of breast implant and augmentation surgeries are performed in hospitals owing to the rising preference of patients to be treated in a professional environment with experienced surgeons. Surging healthcare expenditure is also a factor that is favoring sales of breast implants in hospitals in the Asia Pacific region.

Competitive Landscape

Breast implant suppliers in the Asia Pacific region are stressing obtaining new approvals from regulatory bodies for their innovative products to improve their sales potential in the future.

• In November 2023, Establishment Labs Holdings, an aesthetics and medical technology organization based in Costa Rica, announced that it had received approval for its Motiva® Implants in China. With this National Medical Products Administration (NMPA) approval, Establishment Labs entered China, which leads the demand for breast implants in the Asia Pacific region.

Segmentation of Breast Implant Study in Asia Pacific

• By Product Type :

  • Silicone Breast Implants
  • Saline Breast Implants

• By Shape :

  • Round Breast Implants
  • Anatomical Breast Implants

• By Application :

  • Cosmetic Surgeries
  • Reconstructive Surgeries

• By End User :

  • Hospitals
  • Cosmetic Clinics

• By Country :

  • China
  • Malaysia
  • Thailand
  • Indonesia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific